Transarterial chemoembolization (TACE) combined with sorafenib versus TACE for hepatocellular carcinoma with portal vein tumor thrombus: a systematic review and meta-analysis

BACKGROUND: The benefits of transarterial chemoembolization plus sorafenib (TACE-S) in hepatocellular carcinoma (HCC) with portal vein tumor thrombus (PVTT) remain controversial. We compared the effectiveness and safety of TACE-S and TACE for HCC with PVTT. METHODS: The Cochrane Library, PubMed, EMB...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, XiuPing, Wang, Kang, Wang, Meng, Yang, Guang, Ye, XiaoFei, Wu, MengChao, Cheng, ShuQun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5438741/
https://www.ncbi.nlm.nih.gov/pubmed/28177886
http://dx.doi.org/10.18632/oncotarget.15075

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5438741/
https://www.ncbi.nlm.nih.gov/pubmed/28177886
http://dx.doi.org/10.18632/oncotarget.15075

Ejemplares similares